Literature DB >> 11375954

Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice.

G Barbara1, R De Giorgio, Y Deng, B Vallance, P Blennerhassett, S M Collins.   

Abstract

BACKGROUND & AIMS: Chronic abdominal symptoms develop in some patients after acute enteric infection. This study examined mechanisms underlying smooth muscle hypercontractility that persists after acute infection in mice.
METHODS: Euthymic and athymic National Institutes of Health (NIH) Swiss mice were infected with Trichinella spiralis and studied 4 weeks postinfection (PI). Isometric tension was assessed in longitudinal muscle. Cytokine and cyclooxygenase (COX)-2 messenger RNA was determined in the muscularis externa by reverse-transcription polymerase chain reaction. COX-2 protein was identified by immunohistochemistry and prostaglandin E(2) was measured by enzymatic immunoassay. Studies were performed in euthymic and athymic NIH Swiss mice 28 days PI and in the presence or absence of treatment with corticosteroid or COX inhibitors.
RESULTS: Muscle hypercontractility was evident in euthymic mice but was attenuated in athymic mice or in steroid-treated euthymic mice 28 days PI. Expression of Th2 cytokines interleukins 4, 5, and 13 was increased during the acute infection but not thereafter. COX-2 was localized to muscle and its enzymatic activity remained significantly increased in the muscle on day 28 PI. Selective COX-2 inhibition in vitro reduced the sustained increase in tension generation.
CONCLUSIONS: These findings show that COX-2 activation in resident cells of the muscularis externa contributes to the muscle hypercontractility that persists after infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375954     DOI: 10.1053/gast.2001.24847

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  28 in total

1.  The putative role of inflammation in the irritable bowel syndrome.

Authors:  S M Collins; T Piche; P Rampal
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Effect of probiotics on gastrointestinal function: evidence from animal models.

Authors:  Elena F Verdú; Premysl Bercik; Stephen M Collins
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

4.  Deficient Skeletal Muscle Regeneration after Injury Induced by a Clostridium perfringens Strain Associated with Gas Gangrene.

Authors:  Ana Mariel Zúñiga-Pereira; Carlos Santamaría; José María Gutierrez; Alberto Alape-Girón; Marietta Flores-Díaz
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 5.  Post-infectious irritable bowel syndrome.

Authors:  Marroon Thabane; John K Marshall
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

6.  Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease.

Authors:  M Fornai; R Colucci; L Antonioli; C Ippolito; C Segnani; P Buccianti; A Marioni; M Chiarugi; V Villanacci; G Bassotti; C Blandizzi; N Bernardini
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

Review 7.  Probiotic use in irritable bowel syndrome.

Authors:  Patrick Young; Brooks D Cash
Journal:  Curr Gastroenterol Rep       Date:  2006-08

8.  Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice.

Authors:  E F Verdú; P Bercik; M Verma-Gandhu; X-X Huang; P Blennerhassett; W Jackson; Y Mao; L Wang; F Rochat; S M Collins
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

9.  Development of colorectal sensitization is associated with increased eosinophils and mast cells in dextran sulfate sodium-treated rats.

Authors:  J M Tobin; L M D Delbridge; R Di Nicolantonio; P Bhathal
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

Review 10.  Current insights into the pathophysiology of irritable bowel syndrome.

Authors:  Ines Schwetz; Sylvie Bradesi; Emeran A Mayer
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.